Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
about
Piroxicam-β-cyclodextrin: a GI safer piroxicamGastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesModulation of microbiota as treatment for intestinal inflammatory disorders: An uptodateLong-term use of steroids protects from the development of symptomatic diverticulitis requiring hospitalization in the Asian populationA review of the gastrointestinal safety data--a gastroenterologist's perspective.Patient benefit-risk in arthritis--a rheumatologist's perspective.Understanding and modulating mammalian-microbial communication for improved human health.A perspective on efflux transport proteins in the liverSulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.Myths and facts in the use of anti-inflammatory drugs.Identifying and assessing benefit-risk in primary care--a family physician's perspective.NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategiesManaging the adverse effects of nonsteroidal anti-inflammatory drugs.NSAID enteropathy: could probiotics prevent it?Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis.Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy.Potentiated clinoptilolite: artificially enhanced aluminosilicate reduces symptoms associated with endoscopically negative gastroesophageal reflux disease and nonsteroidal anti-inflammatory drug induced gastritisProtons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.The effect of rifaximin on gut flora and Staphylococcus resistance.Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam
P2860
Q27023475-ECAA047C-AEE1-4274-AF33-F8E4E5913C54Q27026351-75CCEB05-1DCE-434C-B92B-3B0F5698FD4EQ28072437-D17256AD-881C-44C7-A676-2D73592F40EAQ28546806-B3F118DC-9184-4B42-B530-B1FD1C11A145Q33560647-7F0E0563-F3B9-4445-B984-E5592C268DFDQ33803037-65D9E35B-E081-4A16-AC8A-8C8582A7627BQ35026463-91E0C757-7052-4A25-B771-830E335D9B18Q37050337-E76FFCA9-47BD-42E2-BF73-745334FACEB2Q37437230-2FC92BE7-3CFC-481C-851E-ECE7CDDB0708Q37476911-CA1BA442-B1D3-4B4C-8311-FBA42E696B7BQ37734731-C259BF59-DD4B-4643-A1E2-9BA48E096D08Q37882741-30FD00AF-93DF-467F-931A-2FA1A31F053CQ37960540-EB9241F5-7DEB-47CE-B1D8-306307966810Q38033092-EC30E5EE-955B-437B-8297-1C53B0DA41DEQ38097424-19A6E8CC-0D0E-4B6A-AE88-B76951B5F1B0Q38260626-0C54E973-0E91-4CD2-AF87-DF1A57CB1E7EQ38633511-FC385E59-B9C3-400F-A4AF-F1A144211546Q38707937-E05C2D2A-BA8B-4707-8BA8-3C347FB5B746Q38850732-94F6B7A6-B9EB-4897-87B0-F6CBF361F89BQ39447895-C63F2966-E0B7-4D1E-A680-AC50A2D6661EQ42235939-B1DF40B1-E785-4329-8D32-12A9CB4AD5EDQ42340034-FCB50143-56F5-4F84-8291-49AFF4E27875Q53781806-2E54BE16-5299-45EA-BDFC-B6551894F954Q54263702-F45ABCCF-2680-4DDF-909E-E41B9295F65EQ57541211-141A1F29-9395-4F3E-9D4E-B7F5E803D20D
P2860
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@ast
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@en
type
label
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@ast
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@en
prefLabel
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@ast
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@en
P2860
P356
P1433
P1476
Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?
@en
P2093
Angel Lanas
Carmelo Scarpignato
P2860
P304
P356
10.1159/000089789
P478
73 Suppl 1
P577
2006-02-08T00:00:00Z